Mark Rosenthal - Concepedia

Author

Mark Rosenthal

Also Known As

C. Brown, CABARET/COGNO investigators, M A Rosenthal, M Rosenthal, M. A Rosenthal, M. A. ROSENTHAL, M. A. Rosenthal, M. J. Rosenthal, M. Rosenthal, M.A. ROSENTHAL

351

Publications

15.6K

Citations

H-Index

134

Concepts

All Affiliations

The Royal Melbourne Hospital Peter MacCallum Cancer Centre The University of Melbourne Austin Health National Health and Medical Research Council

About

Mark Rosenthal is an author at The Royal Melbourne Hospital specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	61	2.8K
2	Health Sciences	11	12	457
3	Arts	1	1	26
4	Engineering	1	1	112
5	Natural Sciences	1	1	69

Mark Rosenthal

122

Publications

12.6K

Citations

H-Index

Page 1

	Year	Citations
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer Ian F. Tannock, Ronald de Wit, William R. Berry, New England Journal of Medicine	2004	5.7K
Reference Ranges for Spirometry Across All Ages Sanja Stanojevic, Angie Wade, Janet Stocks, American Journal of Respiratory and Critical Care Medicine	2007	686
Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma Tracy T. Batchelor, Paul Mulholland, Bart Neyns, Journal of Clinical Oncology	2013	585
Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors Scott N. Holden, Sabine Eckhardt, R. Basser, Annals of Oncology MedicinePharmacologyPathologyMalignant TumorsAnti-cancer Agent	2005	306
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial Ian F. Tannock, Karim Fizazi, Camilla Thellenberg Karlsson, The Lancet Oncology Aflibercept Versus PlaceboUrologyOncologyMedicineClinical Trials	2013	285
Lung function in white children aged 4 to 19 years: I--Spirometry. Mark Rosenthal, S H Bain, D. Cramer, Thorax	1993	260
Lung function in white children aged 4 to 19 years: II--Single breath analysis and plethysmography. Mark Rosenthal, D. Cramer, S H Bain, Thorax	1993	174
Glutamate is associated with a higher risk of seizures in patients with gliomas Tanya Yuen, Andrew Morokoff, Andrew R. Bjorksten, Neurology	2012	171
Longitudinal Evaluation of Airway Function 21 Years after Preterm Birth Indra Narang, Mark Rosenthal, David Cremonesini, American Journal of Respiratory and Critical Care Medicine	2008	165
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide G. Dresemann, Michael Weller, Mark Rosenthal, Journal of Neuro-Oncology Neuro-oncologyOncologyMedicineGlioblastoma ResistantDose Temozolomide	2009	153

Page 1